Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria

Clinical Microbiology Reviews

Volumn 19, Issue 2, 2006, Pages 382-402

  Piddock, Laura J V ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIFLAVINE; ALKALOID; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BILE SALT; CARRIER PROTEIN; CEFSULODIN; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; ERYTHROMYCIN; ETHIDIUM BROMIDE; FUSIDIC ACID; GENTAMICIN; IMIPENEM; MULTIDRUG RESISTANCE EFFLUX PUMP; NALIDIXIC ACID; NETILMICIN; NOVOBIOCIN; OFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SHORT CHAIN FATTY ACID; TETRACYCLINE; TETRACYCLINE DERIVATIVE; TIMENTIN; TOBRAMYCIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL INFECTION; BACTERIAL SURVIVAL; BACTERIUM ISOLATE; DRUG TRANSPORT; ECOLOGICAL NICHE; GENE INSERTION SEQUENCE; GENOMICS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MULTIDRUG RESISTANCE; MYCOBACTERIUM; NODULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PROMOTER REGION; PROTEIN FUNCTION; REGULATOR GENE; REPRESSOR GENE; REVIEW;

ALKALOIDS; ANTI-INFECTIVE AGENTS; BACTERIA; BACTERIAL PROTEINS; BIOLOGICAL TRANSPORT; CHROMOSOMES, BACTERIAL; DISINFECTANTS; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, REGULATOR; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; MUTATION; PROMOTER REGIONS (GENETICS); VIRULENCE;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM; NEGIBACTERIA; POSIBACTERIA;

EID: 33646251815     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.19.2.382-402.2006     Document Type: Review

References (239)

1. Aires, J. R., T. Kohler, H. Nikaido, and P. Plesiat. 1999. Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob. Agents Chemother. 43:2624-2628.
2. Aires, J. R., and H. Nikaido. 2005. Aminoglycosides are captured from both periplasm and cytoplasm by the AcrD multidrug efflux transporter of Escherichia coli. J. Bacteriol. 187:1923-1929.
3. Akama, H., M. Kanemaki, M. Yoshimura, T. Tsukihara, T. Kashiwagi, H. Yoneyama, S. Narita, A. Nakagawa, and T. Nakae. 2004. Crystal structure of the drug discharge outer membrane protein, OprM, of Pseudomonas aeruginosa: dual modes of membrane anchoring and occluded cavity end. J. Biol. Chem. 279:52816-52819.
4. Akama, H. T., T. Matsuura, S. Kashiwagi, H. Yoneyama, S. Narita, T. Tsukihara, A. Nakagawa, and T. Nakae. 2004. Crystal structure of the membrane fusion protein, MexA, of the multidrug transporter in Pseudomonas aeruginosa. J. Biol. Chem. 279:25939-25942.
5. Alekshun, M. A., and S. B. Levy. 2004. The Escherichia coli mar locus-antibiotic resistance and more. ASM News 70:451-456.
6. Alekshun, M. A., and S. B. Levy. 1997. Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon. Antimicrob. Agents Chemother. 41:2067-2075.
7. Amaral, L., M. Viveiros, and J. Molnar. 2004. Antimicrobial activity of phenothiazines. In Vivo 18:725-731.
8. Amyes, S. A. 2005. Treatment of staphylococcal infection. Br. Med. J. 330:976-977.
9. Aono, R., M. Kobayashi, H. Nakajima, and H. Kobayashi. 1995. A close correlation between improvement of organic-solvent tolerance levels and alteration of resistance towards low-levels of multiple antibiotics in Escherichia coli. Biosci. Biotechnol. Biochem. 59:213-218.
10. Banerjee, S. K., K. Bhatt, P. Misra, and P. K. Chakraborti. 2000. Involvement of a natural transport system in the process of efflux-mediated drug resistance in Mycobacterium smegmatis. Mol. Gen. Genet. 262:949-956.
11. Baranova, N. N., and A. A. Neyfakh. 1997. Apparent involvement of a multidrug transporter in the fluoroquinolone resistance of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41:1396-1398.
12. Baucheron, S., H. Imberechts, E. Chaslus-Dancla, and A. Cloeckaert. 2002. The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar Typhimurium phage type DT204. Microb. Drug Resist. 8:281-289.
13. Baucheron, S., C. Mouline, K. Praud, E. Chaslus-Dancla, and A. Cloeckaert. 2005. TolC but not AcrB is essential for multidrug-resistant Salmonella enterica serotype Typhimurium colonization of chicks. J. Antimicrob. Chemother. 55:707-712.
14. Baucheron, S., S. Tyler, D. Boyd, M. R. Mulvey, E. Chaslus-Dancla, and A. Cloeckaert. 2004. AcrAB-TolC directs efflux-mediated multidrug resistance in Salmonella enterica serovar Typhimurium DT104. Antimicrob. Agents Chemother. 48:3729-3735.
15. Baucheron, S. E., Chaslus-Dancla, and A. Cloeckaert. 2004. Role of TolC and parC mutation in high-level fluorquinolone resistance in Salmonella enterica serotype Typhimurium DT204. J. Antimicrob. Chemother. 53:657-659.
16. Begley, M., C. G. M. Gahan, and C. Hill. 2005. The interaction between bacteria and bile. FEMS Microbiol. Rev. 29:625-651.
17. Bennik, M. H., P. J. Pomposiello, D. F. Thorne, and B. Demple. 2000. Defining a rob regulon in Escherichia coli by using transposon mutagenesis. J. Bacteriol. 182:3794-3801.
18. Bohnert, J. A., and W. Kern. 2005. Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps. Antimicrob. Agents Chemother. 49:849-852.
19. Borges-Walmsley, M. I., K. S. McKeegan, and A. R. Walmsley. 2003. Structure and function of efflux pumps that confer resistance to drugs. Biochem. J. 376:313-338.
20. Bouteille, D., S. Corvee, N. Caroff, C. Giraudeau, E. Espaze, J. Caillon, P. Plesiat, and A. Reynaud. 2004. Detection of an IS21 insertion sequence in the mexR gene of Pseudomonas aeruginosa increasing beta-lactam resistance. FEMS Microbiol. Lett. 230:143-146.
21. Braibant, M. L., Guilloteau, and M. S. Zygmunt. 2002. Functional characterization of Brucella melitensis NorMI, an efflux pump belonging to the multidrug and toxic compound extrusion family. Antimicrob. Agents Chemother. 46:3050-3053.
22. Brenwald, N. P., M. J. Gill, and R. Wise. 1997. The effect of reserpine, an inhibitor of multi-drug efflux pumps, on the in vitro susceptibilities of fluoroquinolone-resistant strains of Streptococcus pneumoniae to norfloxacin. J. Antimicrob. Chemother. 40:458-460.
23. Brenwald, N. P., M. J. Gill, and R. Wise. 1998. Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42:2032-2035.
24. Brosky, J., K. Coleman, M. N. Gwynn, L. McClosky, C. Traini, L. Voelker, and R. Warren. 2000. Efflux and target mutations as quinolone resistance mechanisms in clinical isolates of Streptococcus pneumoniae. J. Antimicrob. Chemother. 45(Suppl. 1):95-99.
25. Buckley, A., S. Cooles, L. Randall, R. M., La Ragione, M. Woodward, and L. J. V. Piddock. The AcrAB-TolC efflux system of Salmonella enterica serovar Typhimurium plays a role in pathogenesis. Cell. Microbiol., in press.
26. Burse, E., H. Weingart, and M. S. Ullrich. 2004. The phytoalexin- inducible multidrug efflux pump AcrAB contributes to virulence in the fire blight pathogen, Erwinia amylovora. Mol. Plant-Microbe Interact. 17:43-54.
27. Cagliero, C., L. Cloix, S. Payot, and A. Cloeckaert. 2004. High genetic variation of the multidrug transporter gene cmeB in Campylobacter jejuni and Campylobacter coli. Int. J. Antimicrob. Agents 24:8107.
28. Cao, L., R. Srikumar, and K. Poole. 2004. MexAB-OprM hyperexpression in NalC-type nultidrug resistant Pseudomonal aeruginosa: identification and chracterization of the nalC gene encoding a repressor of PA3720-PA3719. Mol. Microbiol. 53:1423-1436.
29. Chollet, R., J. Chevalier, C. Bollet, J. M. Pages, and A. Davin-Regli. 2004. RamA is an alternate activator of the multidrug resistance cascade in Enterobacter aerogenes. Antimicrob. Agents Chemother. 48:2518-2523.
30. Chollet, R., J. Chevalier, A. Bryskier, and J. M. Pages. 2004. The AcrAB-TolC pump is involved in macrolide resistance but not in telithromycin efflux in Enterobacter aerogenes and Escherichia coli. Antimicrob. Agents Chemother. 48:3621-3624.
31. Chuanchuen, R., T. Murata, N. Gotoh, and H. P. Schweizer. 2005. Substrate-dependent utilization of OprM or OpmH by the Pseudomonas aeruginosa MexJK efflux pump. Antimicrob. Agents Chemother. 49:2133-2136.
32. Chuanchuen, R., C. T. Narasaki, and H. P. Schweizer. 2002. The MexJK efflux pump of Pseudomonas aeruginosa requires OprM for antibiotic efflux but not for efflux of triclosan. J. Bacteriol. 184:5036-5044.
33. Chuanchuen, R., J. B. Gaynor, R. Karkhoff-Schweizer, and H. P. Schweizer. 2005. Molecular characterization of MexL, the transcriptional repressor of the mexJK multidrug efflux operon in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49:1844-1851.
34. Chuanchuen, R., R. R. Karkhoff-Schweizer, and H. P. Schweizer. 2003. High-level triclosan resistance in Pseudomonas aeruginosa is solely a result of efflux. Am. J. Infect. Control 31:124-127.
35. Cohen, S. P., L. M. McMurry, D. C. Hooper, J. S. Wolfson, and S. B. Levy. 1989. Cross-resistance to fluoroquinolones in multiple antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrob. Agents Chemother. 33:1318-1325.
36. Colangeli, R., D. Helb, S. Sridharan, J. Sun, M. Varma-Basil, M. H. Hazbon, R. Harbacheuski, N. J. Megjugorac, W. R. Jacobs, A. Holzenburg, J. C. Sacchettimi, and D. Alland. 2005. The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol. Mol. Microbiol. 55:1829-1840.
37. Dean, C. R., M. A. Visalli, S. J. Projan, P. E. Sum, and P. A. Bradford. 2003. Efflux-mediated resistance to tigecylcine (GAR-936) in Pseudomonas aeuroginosa PAO1. Antimicrob. Agents Chemother. 47:972-978.
38. Delihas, N., and S. Forst. 2001. MicF: an antisense RNA gene involved in response of Escherichia coli to global stress factors. J. Mol. Biol. 313:1-12.
39. Diekema, D. J., M. A. Pfaller, F. J. Schmitz, J. Smayevsky, J. Bell, R. N. Jones, M. Beach, and the SENTRY Participants Group. 2001. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY antimicrobial surveillance program, 1997-1999. Clin. Infect. Dis. 32:5114-S132.
40. 39a.Dupont, P., D. Hocquet, K. Jeannot, P. Chavanet, and P. Plesiat. 2005. Bacteriostatic and bactericidal activities of eight fluoroquinolones against MexAB-OprM-overproducing strains of Pseudomonas aeuroginosa. J. Antimicrob. Chemother. 55:518-522.
41. Eaves, D. J., V. Ricci, and L. J. Piddock. 2004. Expression of acrB, acrF, acrD, marA, and soxS in Salmonella enterica serovar Typhimurium: role in multiple antibiotic resistance. Antimicrob. Agents Chemother. 48:1145-1150.
42. Escribano, I., J. C. Rodriguez, L. Cebrian, and G. Royo. 2004. The importance of active efflux systems in the quinolone resistance of clinical isolates of Salmonella spp. Int. J. Antimicrob. Agents 24:428-432.
43. Eswaran, J., E. Koronakis, M. K. Higgins, C. Hughes, and V. Koronakis. 2004. Three's company: component structures bring a closer view of tripartite drug efflux pumps. Curr. Opin. Struct. Biol. 14:741-747.
44. Evans, K., L. Passador, R. Srikumar, E. Tsang, J. Nezezon, and K. Poole. 1998. Influence of the MexAB-OprM multidrug efflux system on quorum sensing in Pseudomonas aeroginosa. J. Bacteriol. 180:5443-5447.
45. Everett, M. J., Y.-F. Jin, V. Ricci, and L. J. V. Piddock. 1996. Contribution of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli isolates from humans and animals. Antimicrob. Agents Chemother. 40:2380-2386.
46. Fernandes, P., B. S. Ferreira, and J. M. Cabral. 2003. Solvent tolerance in bacteria: role of efflux pumps and cross-resistance with antibiotics. Int. J. Antimicrob. Agents 22:211-216.
47. Folster, J. P., and W. M. Shafer. 2005. Regulation of mtrF expression in Neisseria gonorrhoeae and its role in high-level antimicrobial resistance. J. Bacteriol. 187:3713-3720.
48. Fournier, B., R. Aras, and D. C. Hooper. 2000. Expression of the multidrug resistance transporter NorA from Staphylococcus aureus is modified by a two-component regulatory system. J. Bacteriol. 182:665-671.
49. Fournier, B., Q. C. Truong-Bolduc, X. Zhang, and D. C. Hooper. 2001. A mutation in the 5′ untranslated region increases stability of norA mRNA, encoding a multidrug resistance transporter of Staphylococcus aureus. J. Bacteriol. 183:2367-2371.
50. George, A. M., R. M. Hall, and H. W. Stokes. 1995. Multidrug resistance in Klebsiella pneumoniae: a novel gene, ramA, confers a multidrug resistance phenotype in Escherichia coli. Microbiology 141:1909-1920.
51. George, A. M., and S. B. Levy. 1983. Gene in the major co-transduction gap of the Escherichia coli K-12 linkage map required for the expression of chromosomal resistance to tetracycline and other antibiotics. J. Bacteriol. 155-541-548.
52. Gerken, H., and R. Misra. 2004. Genetic evidence for functional interactions between TolC and AcrA proteins of a major antibiotic efflux pump of Escherichia coli. Mol. Microbiol. 54:620-631.
53. Gibbons, S., E. Moser, and G. W. Kaatz. 2004. Catechin gallates inhibit multidrug resistance (MDR) in Staphylococcus aureus. Planta Med. 70:1240-1242.
54. Gibbons, S., B. Ohlendorf, and I. Johnsen. 2002. The genus Hypericum-a valuable resource of anti-Staphylococcal leads. Fitoterapia 73:300-304.
55. Gibbons, S., M. Oluwatuyi, N. C. Veitch, and A. I. Gray. 2003. Bacterial resistance modifying agents from Lycopus europaeus. Phytochemistry 62:83-87.
56. Gill, M. J., N. P. Brenwald, and R. Wise. 1999. Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 43:187-189.
57. Giraud, E., A. Cloeckaert, D. Kerboeuf, and E. Chaslus-Dancla. 2000. Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar Typhimurium. Antimicrob. Agents Chemother. 44:1223-1228.
58. Guz, N. R., F. R. Stermitz, J. B. Johnson, T. D. Beeson, S. Willen, J.-F. Hsiang, and K. Lewis. 2001. Flavonolignan and flavone inhibitors of a Staphylococcus aureus multidrug resistance pump: structure-activity relationships. J. Med. Chem. 44:261-268.
59. +-coupled multidrug efflux pump, PmpM, a member of the MATE family of transporters, from Pseudomonas aeroginosa. J. Bacteriol. 186:262-265.
60. Higgins, M. K., E. Bokma, E. Koronakis, C. Hughes, and V. Koronakis. 2004. Structure of the periplasmic component of a bacterial efflux pump. Proc. Natl. Acad. Sci. USA 101:9994-9999.
61. Higgins, P. G., H. Wisplingnoff, D. Stefanik, and H. Seifert. 2004. Selection of topoisomerase mutations and overexpresssion of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii. Antimicrob. Agents Chemother. 54:821-823.
62. Hirakata, Y., R. Srikumar, K. Poole, N. Gotoh, T. Suematsu, S. Kohno, S. Kamihira, R. E. Hancock, and D. P. Speert. 2002. Multidrug efflux systems play an important role in the invasiveness of Pseudomonas aeroginosa. J. Exp. Med. 196:109-118.
63. Hocquet, D., X. Bertand, T. Kohler, D. Talon, and P. Plesiat. 2003. Genetic and phenotypic variations of a resistant Pseudomonas aeroginosa epidemic clone. Antimicrob. Agents Chemother. 47:1887-1894.
64. Hooper, D. C. 2005. Efflux pumps and nosocomial antibiotic resistance: a primer for hospital epidemiologists. Clin. Infect. Dis. 40:1811-1817.
65. Hsieh, P.-C., S. A. Siegel, B. Rogers, D. Davis, and K. Lewis. 1998. Bacteria lacking a multidrug pump: a sensitive tool for drug discovery. Proc. Natl. Acad. Sci. USA 95:6602-6606.
66. Huda, M. N., J. Chen, Y. Monta, T. Kuroda, T. Mizushima, and T. Tsuchiya. 2003. Gene cloning and characterization of VcrM, Na+-coupled multidrug efflux pump, from Vibrio cholerae non-O1. Microbiol. Immunol. 47:419-427.
67. Huda, M. N., Y. Morita, T. Kuroda, T. Mizushima, and T. Tsuchiya. 2001. Na+-driven multidrug efflux pump VcmA from Vibrio cholerae non-O1, a non-halophilic bacterium. FEMS Microbiol. Lett. 203:235-239.
68. Jellen-Ritter, A. S., and W. V. Kern. 2001. Enhanced expression of the multidrug efflux pumps AcrAB and AcrEF associated with insertion element transposition in Escherichia coli mutants selected with a fluoroquinolone. Antimicrob. Agents Chemother. 45:1467-1472.
69. Jerse, A. E., N. D. Sharma, A. N. Simms, E. T. Crow, L. A. Snyder, and W. M. Shafer. 2003. A gonococcal efflux pump system enhances bacterial survival in a female mouse model of genital tract infection. Infect. Immun. 71:5576-5582.
70. Johnson, K. W., D. Lofland, and H. E. Moser. 2005. PDF inhibitors: an emerging class of antibacterial drugs. Curr. Drug Targets Infect. Disord. 5:39-52.
71. Jones, M. E., N. M. Boenink, J. Verhoef, K. Kohrer, and F.-J. Schmitz. 2000. Multiple mutations conferring ciprofloxacin resistance in Staphylococcus aureus demonstrate the long term stability in an antibiotic free environment. J. Antimicrob. Chemother. 45:353-356.
72. Kaatz, G. W. 2005. Bacterial efflux pump inhibition. Curr. Opin. Investig. Drugs 6:191-198.
73. Kaatz, G. W., and S. M. Seo. 1995. Inducible NorA-mediated multidrug resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 39:260-2655.
74. Kaatz, G. W., and S. M. Seo. 1997. Mechanisms of fluoroquinolone resistance in genetically related strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 43:2733-2737.
75. Kaatz, G. W., F. McAleese, and S. M. Seo. 2005. Multidrug resistance in Staphylococcus aureus due to overexpression of a novel multidrug and toxin extrusion (MATE) transport protein. Antimicrob. Agents Chemother. 49:1857-1864.
76. Kaatz, G. W., V. V. Moudgal, S. M. Seo, J. B. Hansen, and J. E. Kristiansen. 2003. Phenothylpiperadine selective serotonin reuptake inhibitors interfere with multidrug efflux pump activity in Staphylococcus aureus. Int. J. Antimicrob. Agents 22:254-261.
77. Kaatz, G. W., V. V. Moudgal, S. M. Seo, and J. E. Kristiansen. 2003. Phenothiazines and thioxanthenes inhibit multidrug efflux pump activity in Staphylococcus aureus. Antimicrob. Agents Chemother. 47:719-726.
78. Kaatz, G. W., S. M. Seo, and C. A. Ruble. 1993. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 37:1086-1094.
79. Kaatz, G. W., R. V. Thyagarajan, and S. M. Seo. 2005. Effect of promoter region mutations and mgrA overexpression on transcription of norA, which encodes a Staphylococcus aureus multidrug efflux transporter. Antimicrob. Agents Chemother. 49:161-169.
80. Kaczmarek, F. S., T. D. Gootz, F. Dib-Hajj, W. Shang, S. Hallowell, and M. Cronan. 2004. Genetic and molecular characterization of β-lactamase- negative ampicillin-resistant Haemophilus influenzae with unusually high resistance to ampicillin. Antimicrob. Agents Chemother. 48:1630-1639.
81. Kallman, O., F. Fendukly, I. Karlsson, and G. Kronvall. 2003. Contribution of efflux to cefuroxime resistance in clinical isolates of Escherichia coli. Scand. J. Infect. Dis. 35:464-470.
82. Kanamaru, K., I. Tatsuno, T. Tobe, and C. Sasakawa. 2000. SdiA, an Escherichia coli homologue of quorum-sensing regulators, controls the expression of virulence factors in enterohaemorrhagic Escherichia coli O157: H7. Mol. Microbiol. 38:805-816.
83. Kim, S. H., A. B. Chang, and M. H. Saier. 2004. Sequence similarity between multidrug resistance efflux pumps of the ABC and RND superfamilies. Microbiology 150:2493-2495.
84. Klyachko, K. A., S. Schuldiner, and A. A. Neyfakh. 1997. Mutations affecting substrate specificity of the Bacillus subtilis multidrug transporter Bmr. J. Bacteriol. 179:2189-2193.
85. Kohler, T., S. F. Epp, L. K. Curty, and J. C. Pechere. 1999. Chracterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeroginosa. J. Bacteriol. 181:6300-6305.
86. Koronakis, V., J. Eswaran, and C. Hughes. 2004. Structure and function of TolC: the bacterial exit duct for proteins and drugs. Annu. Rev. Biochem. 73:467-489.
87. Koronakis, V., A. Sharff, E. Koronakis, B. Luisi, and C. Hughes. 2000. Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export. Nature 405:914-919.
88. Koutsolioutsou, A. E., A. Martins, D. G. White, S. B. Levy, and B. Demple. 2001. A soxRS-constitutive mutation contributing to antibiotic resistance in a clinical isolate or Salmonella enterica (serovar Typhimurium). Antimicrob. Agents Chemother. 45:38-43.
89. Koutsolioutsou, A. E., S. Peña-Llopis, and B. Demple. 2005. Constitutive soxR mutations contribute to multiple-antibiotic resistance in clinical Escherichia coli isolates. Antimicrob. Agents Chemother. 49:2746-2752.
90. Kriengkauykiat, J., E. Porter, O. Lomovskaya, and A. Wong-Beringer. 2005. Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeroginosa. Antimicrob. Agents Chemother. 49:565-570.
91. Kristiansen, M. M., C. Leandro, D. Ordway, M. Martins, M. Viveiros, T. Pacheco, J. E. Kristiansen, and L. Amaral. 2003. Phenothiazines alter resistance of methicillin-resistant strains of Staphylococcus aureus (MRSA) to oxacillin in vitro. Int. J. Antimicrob. Agents 22:250-253.
92. Kumar, A., and E. A. Worobec. 2005. Cloning, sequencing and characterization of the SdeAB multidrug efflux pump of Serratia marcescens. Antimicrob. Agents Chemother. 49:1495-1501.
93. Lacroix, F. J.-C., A. Cloeckaert, O. Grepinet, C. Pinault, M. Y. Popoff, H. Waxin, and P. Pardon. 1996. Salmonella typhimurium acrB-like gene: identification and role in resistance to biliary salts and detergents and in murine infection. FEMS Microbiol. Lett. 135:161-167.
94. Le Thomas, I., G. Couetdic, O. Clermont, N. Brahimi, P. Plesiat, and E. Bingen. 2001. In vivo selection of a target/efflux double mutant of Pseudomonas aeroginosa by ciprofloxacin therapy. J. Antimicrob. Chemother. 48:553-555.
95. Levy, S. B. 2002. Active efflux, a common mechanism for biocide and antibiotic resistance. J. Appl. Microbiol. 92:65S-71S.
96. Lewis, K. 2001. In search of natural substrates and inhibitors of MDR pumps. J. Mol. Microbiol. Biotechnol. 3:247-254.
97. Li, X., and H. Nikaido. 2004. Efflux mediated drug resistance in bacteria. Drugs 64:159-204.
98. Li, X. Z., D. M. Livermore, and H. Nikaido. 1994. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeroginosa: resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrob. Agents Chemother. 38:1732-1741.
99. Li, X. Z., L. Zhang, and H. Nikaido. 2004. Efflux pump-mediated intrinsic drug resistance in Mycobacterium smegmatis. Antimicrob. Agents Chemother. 48:2415-2423.
100. Lin, J., M. Akiba, O. Sahin, and Q. Zhang. 2005. CmeR functions as a transcriptional repressor for the multidrug efflux pump CmeABC in Campylobacter jejuni. Antimicrob. Agents Chemother. 49:1067-1075.
101. Lin, J., L. M. Overbye, and Q. Zhang. 2002. CmeABC functions as a multidrug efflux system in Campylobater jejuni. Antimicrob. Agents Chemother. 46:2124-2131.
102. Lin, J., O. Sahin, L. O. Michel, and Q. Zhang,. 2003. Critical role of multidrug efflux pump CmeABC in bile resistance and in vivo colonization of Campylobacter jejuni. Infect. Immun. 71:4250-4259.
103. Linares, J. F., J. A. Lopez, E. Camafeita, J. P. Albar, F. Rojo, and J. L. Martinez. 2005. Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeroginosa. J. Bacteriol. 187:1384-1391.
104. Livermore, D. L. 2003. Linezolid in vitro: mechanism and antibacterial spectrum. J. Antimicrob. Chemother. 51(Suppl. 2):9-16.
105. Livermore, D. M., and K. W. M. Davy. 1991. Invalidity for Pseudomonas aeroginosa of an accepted model of bacterial permeability to β-lactam antibiotics. Antimicrob. Agents Chemother. 35:916-921.
106. Llanes, C., D. Hocquet, C. Vogne, D. Benali-Baitich, C. Neuwirth, and P. Plesiat. 2004. Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously. Antimicrob. Agents Chemother. 48:1797-1802.
107. Lomovskaya, O., M. Warren, A. Lee, J. Galazzo, R. Fronko, M. Lee, J. Blais, D. Cho, S. Chamberland, T. Renau, R. Leger, S. Hecker, W. Watkins, K. Hoshino, H. Ishida, and V. J. Lee. 2001. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeroginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 45:105-116.
108. Lomovskaya, O., and W. Watkins. 2001. Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria. J. Mol. Microbiol. Biotechnol. 3:225-236.
109. Luo, N., O. Sahin, J. Lin, L. O. Michel, and Q. Zhang. 2003. In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump. Antimicrob. Agents Chemother. 47:390-394.
110. Luppens, S. B. I., M. W. Reij, R. W. L. van der Heijden, F. M. Rombouts, and T. Abee. 2002. Development of a standard test to assess the resistance of Staphylococcus aureus biofilm cells to disinfectants. Appl. Environ. Microbiol. 68:4194-4200.
111. Ma, D., D. N. Cook, M. Alberti, N. G. Pon, H. M. Nikaido, and E. Hearst. 1993. Molecular cloning of acrA and acrE genes of Escherichia coli. J. Bacteriol. 175:6299-6313.
112. Ma, D., D. N. Cook, M. Alberti, N. G. Pon, H. Nikaido, and J. E. Hearst. 1995. Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli. Mol. Microbiol. 16:45-55.
113. Magnet, S., P. Courvalin, and T. Lambert. 2001. Resistance-nodulation- cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob. Agents Chemother. 45:3375-3380.
114. Malléa, M., J. Chevalier, A. Eyraud, and J.-M. Pagès. 2002. Inhibitors of antibiotic efflux pump in resistant Enterobacter aerogenes strains. Biochem. Biophys. Res. Commun. 293:1370-1373.
115. Mamelli, L, J.-P. Amoros, J.-M. Pagès, and J.-M. Bolla. 2003. A phenylalanine arginine beta-naphthylamide sensitive multidrug efflux pump involved in intrinsic and acquired resistance of Campylobacter to macrolides. Int. J. Antimicrob. Agents 22:237-241.
116. Marchand, I., L. Damier-Piolle, P. Courvalin, and T. Lambert. 2004. Expression of the RND-type efflux pump AdeACB in Acinetobacter baumannii is regulated by the AdeRS two-component system. Antimicrob. Agents Chemother. 48:3298-3304.
117. Markham, P. N. 1999. Inhibition of the emergence of ciprofloxacin resistance in Streptococcus pneumoniae by the multidrug efflux inhibitor reserpine. Antimicrob. Agents Chemother. 43:988-989.
118. Markham, P. N., and A. Neyfakh. 1996. Inhibition of the multi-drug transporter norA prevents emergence of norfloxacin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 40:2673-2674.
119. Markham, P. N., E. Westhaus, K. Klyachko, M. E. Johnson, and A. A. Neyfakh. 1999. Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus. Antimicrob. Agents Chemother. 43:2404-2408.
120. Marquez, B. Bacterial efflux systems and efflux pump inhibitors. Biochimie, in press.
121. Marrer, E., T. Satoh, M. M. Johnson, L. J. V. Piddock, and M. G. P. Page. 2006. Global transcriptome analysis of the responses of a fluoroquinolone- resistant Streptococcus pneumoniae mutant and its parent to ciprofloxacin. Antimicrob. Agents Chemother. 50:269-278.
122. Martin, R. G., W. K. Gillette, and J. L. Rosner. 2000. Promoter discrimination by the related transcriptional activators MarA and SoxS: differential regulation by differential binding. Mol. Microbiol. 35:623-634.
123. Masuda, N., E. Sakagawa, S. Ohya, N. Gotoh, H. Tsujimoto, and T. Nishino. 2000. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeroginosa. Antimicrob. Agents Chemother. 44:3322-3327.
124. Mazzariol, A., Y. Tokue, T. M. Kanegawa, G. Cornaglia, and H. Nikaido. 2000. High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA. Antimicrob. Agents Chemother. 44:3441-3443.
125. Mazzariol, A., Y. Tokue, T. M. Kanegawa, G. Cornaglia, and H. Nikaido. 2001. High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA. Antimicrob. Agents Chemother. 45:647. (Erratum.)
126. Mazzariol, A., J. Zuliani, G. Cornaglia, G. M. Rossolini, and R. Fontana. 2002. AcrAB efflux system: expression and contribution to fluoroquinolone resistance in Klebsiella spp. Antimicrob. Agents Chemother. 46:3984-3986.
127. Mazzola, P. G., T. C. V. Penna, and A. M. Martins. 2003. Determination of decimal reduction time (D value) of chemical agents in hospitals for disinfectant purposes. BMC Infect. Dis. 3:24-34.
128. McMurray, L. M., M. Oethinger, and S. B. Levy. 1998. Over-expression of marA, soxS, or acrB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol. Lett. 166:305-309.
129. Miller, P. F., L. F. Gambino, M. C. Sulavik, and S. J. Gracheck. 1994. Genetic relationship between soxRS and mar loci in promoting multiple antibiotic resistance in Escherichia coli. Antimicrob. Agents Chemother. 38:1773-1779.
130. Miyamae, A., O. Ueda, F. Yoshimura, J. Hwang, Y. Tanaka, and H. Nikaido. 2001. A MATE family multidrug efflux transporter pumps out fluoroquinolones in Bacteroides thetaiotaomicron. Antimicrob. Agents Chemother. 45:3341-3346.
131. Molbak, K., D. L. Baggesen, F. M. Aarestrup, J. M. Ebbesen, J. Engberg, K. Frydendahl, P. Gernersmidt, A. M. Peterson, and H. C. Wegener. 1999. An outbreak of multidrug-resistant, quinolone-resistant, Salmonella enterica serotype typhimurium DT104. N. Engl. J. Med. 341:1420-1425.
132. Morel, C., F. R. Stermitz, G. Tegos, and K. Lewis. 2003. Isoflavones as potentiators of antibacterial activity. J. Agric. Food Chem. 51:5677-5679.
133. Morita, Y., K. Kodama, S. Shiota, T. Mine, A. Kataoka, T. Mizushima, and T. Tsuchiya. 1998. NorM. a putative multidrug efflux protein of Vibrio parahaemolyticus and its homolog in Escherichia coli. Antimicrob. Agents Chemother. 42:1778-1782.
134. Murakami, S., R. Nakashima, E. Yamashita, and A. Yamaguchi. 2002. Crystal structure of bacterial multidrug efflux transporter AcrB. Nature 419:587-593.
135. Neyfakh, A. A. 1992. The multidrug efflux transporter of Bacillus subtilis is a structural and functional homolog of the Staphylococcus NorA protein. Antimicrob. Agents Chemother. 36:484-485.
136. Neyfakh, A. A., V. E. Bidnenko, and L. Bo Chen. 1991. Efflux-mediated multidrug resistance in Bacillus subtilis: similarities and dissimilarities with the mammalian system. Proc. Natl. Acad. Sci. USA 88:4781-4785.
137. Neyfakh, A. A., C. M. Borsch, and G. W. Kaatz. 1993. Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter. Antimicrob. Agents Chemother. 37:128-129.
138. Ng, E. Y., M. Truckis, and D. C. Hooper. 1994. Quinolone resistance mediated by NorA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome. Antimicrob. Agents Chemother. 38:1345-1355.
139. Nikaido, H. 1998. Multiple antibiotic resistance and efflux. Curr. Opin. Microbiol. 1:515-523.
140. Nikaido, H. 2003. Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. 67:593-656.
141. Nishino, K., and A. Yamaguchi. 2001. Analysis of the complete library of putative drug transporter genes in Escherichia coli. J. Bacteriol. 183:5803-5812.
142. Noguchi, N., M. Hase, M. Kitta, M. Sasatsu, K. Deguchi, and M. Kono. 1999. Antiseptic susceptibility and distribution of antiseptic-resistance genes in methicillin-resistant Staphvlococcus aureus. FEMS Microbiol. Lett. 172:247-253.
143. Noguchi, N., H. Okada, K. Narui, and M. Sasatsu. 2004. Comparison of the nucleotide sequence and expression of nor/4 genes and microbial susceptibility in 21 strains of Staphylococcus aureus. Microb. Drug Resist. 10:197-203.
144. Noguchi, N., T. Okihara, Y. Namiki, Y. Kumaki, Y. Yamanaka, M. Koyama, K. Wakasugi, and M. Sasatsu. 2005. Susceptibility and resistance genes to fluoroquinolones in methicillin-resistant Staphylococcus aureus isolated in 2002. Int. J. Antimicrob. Agents 25:374-379.
145. Oethinger, M., W. V. Kern, A. S. Jellen-Ritter, L. M. McMurry, and S. B. Levy. 2000. Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob. Agents Chemother. 44:10-13.
146. Oethinger, M., I. Podglajen, W. V. Kern, and S. B. Levy. 1998. Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli. Antimicrob. Agents Chemother. 42:2089-2094.
147. Oh, H., J. Stenhoff, S. Jalal, and B. Wretlind. 2003. Role of efflux pumps and mutations in genes for topoisomerases II and IV in fluoroquinolone-resistant Pseudomonas aeroginosa strains. Microb. Drug Resist. 9:323-328.
148. Oizumi, N., S. Kawabata, M. Hirao, K. Watanabe, S. Okuno, T. Fujiwara, and M. Kikuchi. 2001. Relationship between mutations in the DNA gyrase and topoisomerase IV genes and nadifloxacin resistance in clinically isolated quinolone-resistant Staphylococcus aureus. J. Infect. Chemother. 7:191-194.
149. Okusu, H., D. Ma, and D. Nikaido. 1996. AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants. J. Bacteriol. 178:306-308.
150. Olliver, A., M. Valle, E. Chaslus-Dancla, and A. Cloeckaert. 2004. Role of an acrR mutation in multidrug resistance of in vitro selected fluoroquinolone-resistant mutants of Salmonella enterica serovar Typhimurium. FEMS Microbiol. Lett. 238:267-272.
151. Olliver, A., M. Valle, E. Chaslus-Dancla, and A. Cloeckaert. 2005. Overexpression of the multidrug efflux operon acrEF by insertional activation with IS1 or IS10 elements in Salmonella enterica serovar Typhimurium DT204 acrB mutants selected with fluoroquinolones. Antimicrob. Agents Chemother. 49:289-301.
152. Oluwatuyi, M., G. W. Kaatz, and S. Gibbons. 2004. Antibacterial and resistance modifying activity of Rosmarinus officinalis. Phytochemistry 65:3249-3254.
153. Ordway, D., J. Hohmann, M. Viveiros, A. Viveiros, J. Molnar, C. Leandro,
154. Palma, M., J. Zurita, J. A. Ferreras, S. Worgall, D. H. Larone, L. Shi, F. Campagne, and L. E. Quadri. 2005. Pseudomonas aeroginosa SoxR does not conform to the archetypal paradigm for SoxR-dependent regulation of the bacterial oxidative stress adaptive response. Infect. Immun. 73:2958-2966.
155. Pasca, M. R., P. Guglierame, F. Arcesi, M. Bellinzoni, E. De Rossi, and G. Riccardi. 2004. Rv2686c-Rv2687c-Rv2688c, an ABC fluoroquinolone efflux pump in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 48:3175-3178.
156. Paulsen, I. T. 2003. Multidrug efflux pumps and resistance: regulation and evolution. Curr. Opin. Microbiol. 6:446-451.
157. Paulsen, I. T., J. Chen, K. E. Nelson, and M. H. Saier. 2001. Comparative genomics of microbial drug efflux systems. J. Mol. Microbiol. Biotechnol. 3:145-150.
158. Payne, D. N., J. R. Babb, and C. R. Bradley. 1999. An evaluation of the suitability of the European suspension test to reflect in vitro activity of antiseptics against clinically significant organisms. Lett. Appl. Microbiol. 28:7-12.
159. Payot, S., L. Avrain, C. Magras, K. Praud, A. Cloeckaert, and E. Chaslus-Dancla. 2004. Relative contribution of target gene mutation and efflux to fluoroquinolone and erythromycin resistance in French poultry and pig isolates of Campylobacter coli. Int. J. Antimicrob. Agents 23:468-472.
160. Peric, M., B. Bozdogan, M. R. Jacobs, and P. C. Appelbaum. 2003. Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates. Antimicrob. Agents Chemother. 47:1017-1022.
161. Piddock, L. J. V., D. J. Griggs, M. C. Hall, and Y. F. Jin. 1993. Ciprofloxacin resistance in clinical isolates of Salmonella typhimurium obtained from two patients. Antimicrob. Agents Chemother. 37:662-666.
162. Piddock, L. J. V., M. C. Hall, F. Bellido, M. Bains, and R. E. Hancock. 1992. A pleiotropic, posttherapy, enoxacin-resistant mutant of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 36:1057-1061.
163. Piddock, L. J. V., and M. M. Johnson. 2002. Accumulation of ten fluoroquinolones by wild-type and efflux mutant Streptococcus pneumoniae. Antimicrob. Agents Chemother. 46:813-820.
164. Piddock, L. J. V., M. M. Johnson, S. Simjee, and L. Pumbwe. 2002. Expression of efflux pump gene pmrA in fluoroquinolone-resistant and -susceptible clinical isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 46:808-812.
165. Piddock, L. J. V., M. Johnson, V. Ricci, and S. L. Hill. 1998. Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tract. Antimicrob. Agents Chemother. 42:2956-2960.
166. Piddock, L. J. V., D. G. White, K. Gensberg, L. Pumbwe, and D. J. Griggs. 2000. Evidence for an efflux pump mediating multiple antibiotic resistance in Salmonella enterica serovar Typhimurium. Antimicrob. Agents Chemother. 44:3118-3121.
167. Poole, K. 2005. Efflux mediated antimicrobial resistance. J. Antimicrob. Chemother. 56:20-51.
168. Poole, K. 2004. Efflux mediated multi-resistance in Gram-negative bacteria. Clin. Microbiol. Infect. 10:12-26.
169. Poole, K., K. Krebes, C. McNally, and S. Neshat. 1993. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J. Bacteriol. 175:7363-7372.
170. Poole, K., and R. Srikumar. 2001. Multidrug efflux in Pseudomonas aeruginosa: components, mechanisms and clinical significance. Curr. Top. Med. Chem. 1:59-71.
171. Pos, K. M., A. Schiefner, M. A. Seeger, and K. Diedrichs. 2004. Crystallographic analysis of AcrB. FEBS Lett. 564:333-339.
172. Pradel, E., and J. M. Pages. 2002. The AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes. Antimicrob. Agents Chemother. 46:2640-2643.
173. Prouty, A. M., I. E. Brodsky, S. Falkow, and J. S. Gunn. 2004. Bile-salt-mediated induction of antimicrobial and bile resistance in Salmonella typhimurium. Microbiology 150:775-783.
174. Pumbwe, L., M. J. Everett, R. E. W. Hancock, and L. J. V. Piddock. 1996. Role of gyrA mutation and loss of OprF in the multiple antibiotic resistance (MAR) phenotype of Pseudomonas aeroginosa G49. FEMS Microbiol. Lett. 143:25-28.
175. Pumbwe, L., and L. J. V. Piddock. 2000. Two efflux systems expressed simultaneously in multidrug-resistant Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44:2861-2864.
176. Pumbwe, L., and L. J. V. Piddock. 2002. Identification and molecular characterisation of CmeB, a Campylobacter jejuni multidrug efflux pump. FEMS Microbiol. Lett. 206:185-189.
177. Pumbwe, L., L. P. Randall, M. J. Woodward, and L. J. V. Piddock. 2004. Expression of the efflux pump genes cmeB, cmeF and the porin gene porA in multiply antibiotic-resistant Campylobacter spp. J. Antimicrob. Chemother. 54:341-347.
178. Pumbwe, L., L. P. Randall, M. J. Woodward, and L. J. V. Piddock. 2005. Evidence for multiple antibiotic resistance in Campylobacter jejuni not mediated by CmeB or CmeF. Antimicrob. Agents Chemother. 49:1289-1293.
179. Putman, M., H. W. Van Veen, and W. N. Konings. 2000. Molecular properties of bacterial multidrug transporters. Microbiol. Mol. Biol. Rev. 64:672-693.
180. Rahmati, S., S. Yang, A. L. Davidson, and E. L. Zechiedrich. 2002. Control of the AcrAB multidrug efflux pump by quorum-sensing regulator SdiA. Mol. Microbiol. 43:677-685.
181. Randall, L. P., S. W. Cooles, A. Sayers, and M. Woodward. 2001. Association between cyclohexane resistance in Salmonella of different serovars and increased resistance to multiple antibiotics, disinfectants and dyes. J. Med. Microbiol. 50:919-924.
182. Randall, L. P., and M. J. Woodward. 2001. Multiple antibiotic resistance (mar) locus in Salmonella enterica serovar Typhimurium DT104. Appl. Environ. Microbiol. 67:1190-1197.
183. Ren, Q., K. H. Kang, and I. T. Paulsen. 2004. TransportDB: a relational database of cellular membrane transport systems. Nucleic Acids Res. 32: D284-D288.
184. Renau, T. E., R. Leger, E. M. Flamme, J. Sangalang, M. W. She, R. Yen, C. L. Cannon, D. Griffith, S. Chamberland, O. Lomovskaya, S. J. Hecker, V. J. Lee, T. Ohta, and K. Nakayama. 1999. Inhibitors of efflux pumps in Pseudomonas aeroginosa potentiate the activity of the flouroquinolone antibacterial levofloxacin. J. Med. Chem. 42:4928-4931.
185. Ribera, A., J. Ruiz, M. T. Jiminez de Anta, and J. Vila. 2002. Effect of an efflux pump inhibitor on the MIC of nalidixic acid for Acinetobacter baumannii and Stenotrophomonas maltophilia clinical isolates. J. Antimicrob. Chemother. 49:697-698.
186. Ricci, V., P. Tzakas, A. Buckley, N. Coldham, and L. J. V. Piddock. 2006. Ciprofloxacin-resistant Salmonella enterica serovar Typhimurium strains are difficult to select in the absence of AcrB and TolC. Antimicrob. Agents Chemother. 50:38-42.
187. Robertson, G. T., T. B. Doyle, and A. S. Lynch. 2005. Use of an efflux-deficient Streptococcus pneumoniae strain panel to identify ABC-class multidrug transporters involved in intrinsic resistance to antimicrobial agents. Antimicrob. Agents Chemother. 49:4781-4783.
188. Rosenberg, E. Y., D. Bertenthal, M. L. Nilles, K. P. Bertrand, and H. Nikaido. 2003. Bile salts and fatty acids induce the expression of Escherichia coli AcrAB multidrug efflux pump through their interaction with Rob regulatory protein. Mol. Microbiol. 48:1609-1619.
189. Rosenberg, E. Y., D. Ma, and H. Nikaido. 2000. AcrD of Escherichia coli is an aminoglycoside efflux pump. J. Bacteriol. 182:1754-1756.
190. Rouquette-Loughlin, C., S. A. Dunham, M. Kuhn, J. T. Balthazar, and W. M. Shafer. 2003. The NorM efflux pump of Neisseria gonorrhoeae and Neisseria meningitidis recognizes antimicrobial cationic compounds. J. Bacteriol. 185:1101-1106.
191. Rouquette-Loughlin C., J. B. Harmon, and W. M. Shafer. 1999. Induction of the mirCDE-encoded efflux pump system of Neisseria gonorrhoeae requires MtrA, an AraC-like protein. Mol. Microbiol. 33:651-658.
192. Rouquette-Loughlin, C. E., J. T. Balthazar, S. A. Hill, and W. M. Shafer. 2004. Modulation of the mtrCDE-encoded efflux pump gene complex of Neisseria meningitidis due to a Correia element insertion sequence. Mol. Microbiol. 54:731-741.
193. Russell, A. D. 2003. Biocide use and antibiotic resistance: the relevance of laboratory findings to clinical and environmental situations. Lancet Infect. Dis. 3:794-803.
194. Russell, A. D. 2004. Whither triclosan? J. Antimicrob. Chemother. 53:693-695.
195. Ruzin, A., D. Keeney, and P. A. Bradford. 2005. AcrAB efflux pump plays a role in decreased susceptibility to tigecycline in Morganella morganii. Antimicrob. Agents Chemother. 49:791-793.
196. Saenz, Y., J. Ruiz, M. Zarazaga, M. Teixido, C. Torres, and J. Vila. 2004. Effect of the efflux pump inhibitor Phe-Arg-beta-naphthylamide on the MIC values of the quinolones tetracycline and chloramphenicol in Escherichia coli isolates of different origin. J. Antimicrob. Chemother. 53:544-545.
197. Saier, M. H., Jr., and I. T. Paulsen. 2001. Phytogeny of multidrug transporters. Semin. Cell Dev. Biol. 12:205-213.
198. Sanchez, L., W. Pan, M. Vinas, and H. Nikaido. 1997. The acrAB homolog of Haemophilia influenzae codes for a functional multidrug efflux pump. J. Bacteriol. 179:6855-6857.
199. Sanchez, P., U. Le, and J. L. Martinez. 2003. The efflux pump inhibitor Phe-Arg-beta-naphthylamide does not abolish the activity of the Stenotrophomonas maltophilia SmeDEF multidrug efflux pump. J. Antimicrob. Chemother. 51:1042-1045.
200. Sanchez, P., E. Moreno, and J. L Martinez. 2005. The biocide triclosan selects Stenotrophomonas maltophilia mutants that overproduce the SmeDE multidrug efflux pump. Antimicrob. Agents Chemother. 49:781-782.
201. Schmitz, F.-J., B. Hofmann, S. Scheuring, J. Verhoef, A. C. Fluit, H.-P. Heinz, K. Kohrer, and M. E. Jones. 1998b. Relationship between mutations in the coding and promoter regions of the norA genes in 42 unrelated clinical isolates of Staphylococcus aureus and the MICs of norfloxacin for these strains. J. Antimicrob. Chemother. 42:561-563.
202. Schneiders, T., S. G. Amyes, and S. B. Levy. 2003. Role of AcrR and RamA in fluoroquinolone resistance in clinical Klebsiella pneumoniae isolates from Singapore. Antimicrob. Agents Chemother. 47:2831-2837.
203. Shafer, W. M., J. T. Balthazar, K. E. Hagman, and S. A. Morse. 1995. Missense mutations that alter the DNA-binding domain of the MtrR protein occur frequently in rectal isolates of Neisseria gonorrhoeae that are resistant to faecal lipids. Microbiology 141:907-911.
204. Shiba, T., K. Ishiguro, N, Takemoto, H. Koibuchi, and K. Sugimoto. 1995. Purification and characterization of the Pseudomonas aeruginosa NfxB protein, the negative regulator of the nfxB gene. J. Bacteriol. 177:5872-5877.
205. Siddiqi, N., R. Das, N. Pathak, S. Banerjee, N. Ahmed, V. M. Katoch, and S. E. Hasnain. 2004. Mycobacterium tuberculosis isolate with a distinct genomic identity overexpresses a tap-like efflux pump. Infection 32:109-111.
206. Silva, P. E., F. Bigi, M. de la Paz Santangelo, M. I. Romano, C. Martin, A. Cataldi, and J. A. Ainsa. 2001. Characterization of P55, a multidrug efflux pump in Mycobacterium bovis and Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 45:800-804.
207. Sobel, M. L., D. Hocquet, L. Cao, P. Plesiat, and K. Poole. 2005. Mutations in PA3574 (nalD) lead to increased MexAB-OprM expression and multidrug resistance in laboratory and clinical isolates of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49:1782-1786.
208. Sobel, M. L., S. Neshat, and K. Poole. 2005. Mutations in PA2491 (mexS) promote MexT-dependent mexEF-oprN expression and multidrug resistance in a clinical strain of Pseudomonas aeruginosa. J. Bacteriol. 187:1246-1253.
209. Srikumar, R., T, Kon, N. Gotoh, and K. Poole. 1998. Expression of Pseudomonas aeruginosa multidrug efflux pumps MexA-MexB-OprM and MexC-MexD-OprJ in a multidrug-sensitive Escherichia coli strain. Antimicrob. Agents Chemother. 42:65-71.
210. Stermitz, F. R., T. D. Beeson, P. J. Mueller, J. Hsiang, and K. Lewis. 2001. Staphylococcus aureus MDR efflux pump inhibitors from a Berberis and a Mahonia (sensu strictu) species. Biochem. Syst. Ecol. 29:793-798.
211. Stermitz, F. R., K. K. Cashman, K. M. Halligan, C. Morel, G. P. Tegos, and K. Lewis. 2003. Polyacylated neohesperidosides from Geranium caespitosum: bacterial multidrug resistance pump inhibitors. Bioorg. Med. Chem. Lett. 13:1915-1918.
212. Stermitz, F. R., P. Lorenz, J. N. Tawara, L. A. Zenewicz, and K. Lewis. 2000. Synergy in a medicinal plant: antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor. Proc. Natl. Acad. Sci. USA 97:1433-1437.
213. Stermitz, F. R., L. N. Scriven, G. Tegos, and K. Lewis. 2002. Two flavonols from Artemisa annua which potentiate the activity of berberine and against a norfloxacin resistant strain of Staphylococcus aureus. Planta Med. 68:1140-1141.
214. Stone, B. J., and V. L. Miller. 1995. Salmonella enteritidis has a homologue of tolC that is required for virulence in BALB/c mice. Mol. Microbiol. 17:701-712.
215. Sulavik, M. C., M. Dazer, and P. F. Miller. 1997. The Salmonella typhimurium mar locus: molecular and genetic analyses and assessment of its role in virulence. J. Bacteriol. 179:1857-1866.
216. Sulavik, M. C., C. Houseweart, C. Cramer, N. Jiwani, N. Murgolo, J. Greene, B. DiDomenico, K. J. Shaw, G. H. Miller, R. Hare, and S. Shimer. 2001. Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes. Antimicrob. Agents Chemother. 45:1126-1136.
217. Tegos, G., F. R. Stermitz, O. Lomovskaya, and K. Lewis. 2002. Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials. Antimicrob. Agents Chemother. 46:3133-3141.
218. Thanassi, D. G., L. W. Cheng, and H. Nikaido. 1997. Active efflux of bile salts by Escherichia coli. J. Bacteriol. 179:2512-2518.
219. Truong-Bolduc, Q. C., P. M. Dunman, J. Strahilevitz, S. J. Projan, and D. C. Hooper. 2005. MgrA is a multiple regulator of two new efflux pumps in Staphylococcus aureus. J. Bacteriol. 187:2395-2405.
220. Truong-Bolduc, Q. C., X. Zhang, and D. C. Hooper. 2003. Characterization of NorR protein, a multifunctional regulator of norA expression in Staphylococcus aureus. J. Bacteriol. 185:3127-3138.
221. Urban, M., T. Bhargava, and J. E. Hamer. 1999. An ATP-driven efflux pump is a novel pathogenicity factor in rice blast disease. EMBO J. 18:512-521.
222. van Amsterdam, K., A. Bart, and A. van der Ende. 2005. A Helicobacter pylori TolC efflux pump confers resistance to metronidazole. Antimicrob. Agents Chemother. 49:1477-1482.
223. van der Straaten, T., R. Janssen, D. J. Mevius, and J. T. van Dissel. 2004. Salmonella gene rma (ramA) and multiple-drug-resistant Salmonella enterica Serovar Typhimurium. Antimicrob. Agents Chemother. 48:2292-2294.
224. van Veen, H. W., K. Venema, H. Bolhuis, I. Oussenko, J. Kok, B. Poolman, A. J. Driessen, and W. N. Konings. 1996. Multidrug resistance mediated by a bacterial homolog of the human multidrug transporter MDR1. Proc. Natl. Acad. Sci. USA 93:10668-10672.
225. Veal, W. L., R. A. Nicholas, and W. M. Shafer. 2002. Overexpression of the MtrC-MtrD-MtrE efflux pump due to an mtrR mutation is required for chromosomally mediated penicillin resistance in Neisseria gonorrhoeae. J. Bacteriol. 184:5619-5624.
226. Visalli, M. A., E. Murphy, S. J. Projan, and P. A. Bradford. 2003. AcrAB multidrug efflux pump is associated with reduced levels of susceptibility to tigecycline (GAR-936) in Proteus mirabilis. Antimicrob. Agents Chemother. 47:665-669.
227. Wain, J., N. T. Hoa, N. T. Chinh, H. Vinh, M. J. Everett, T. S. Diep, N. P. Day, T. Solomon, N. J. White, L. J. V. Piddock, and C. M. Parry. 1997. Quinolone-resistant Salmonella typhimurium in Viet Nam: basis of resistance and clinical response to treatment. Clin. Infect. Dis. 25:1404-1410.
228. Webber, M. A., and L. J. V. Piddock. 2001. Absence of mutations in marAB or soxRS in ecrB-overexpressing fluoroquinolone-resistant clinical and veterinary isolates of Escherichia coli. Antimicrob. Agents Chemother. 45:1550-1552.
229. Webber, M. A., A. Talukder, and L. J. V. Piddock. 2005. Contribution of mutation at amino acid 45 of AcrR to acrB expression and ciprofloxacin resistance in clinical and veterinary Escherichia coli isolates. Antimicrob. Agents Chemother. 49:4390-4392.
230. White, D. G., J. D. Goldman, B. Demple, and S. B. Levy. 1997. Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia coli. J. Bacteriol. 179:6122-6126.
231. Wolter, D. J., E. Smith-Moland, R. V. Goering, N. D. Hanson, and P. D. Lister. 2004. Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital. Diagn. Microbiol. Infect. Dis. 50:43-50.
232. Xu, X. J., X. Z. Su, Y. Morita, T. Kuroda, T. Mizushima, and T. Tsuchiya. 2003. Molecular cloning of the HmrM multidrug efflux pump from Haemophilus influenzae Rd. Microbiol. Immunol. 47:937-943.
233. Yoshida, H., M. Bogaki, S. Nakamura, K. Ubukata, and M. Konno. 1990. Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J. Bacteriol. 172:6942-6949.
234. Yu, E. W., J. R. Aires, G. McDermott, and H. Nikaido. 2005. A periplasmic drug-binding site of the AcrB multidrug efflux pump: a crystallographic and site-directed mutagenesis study. J. Bacteriol. 187:6804-6815.
235. Yu, E. W., J. R. Aires, and H. Nikaido. 2003. AcrB multidrug efflux pump of Escherichia coli: composite substrate-binding cavity of exceptional flexibility generates its extremely wide substrate specificity. J. Bacteriol. 185:5657-5664.
236. Yu, E. W., G. McDermott, H. I. Zgurskaya, H. Nikaido, and D. E. Koshland, Jr. 2003. Structural basis of multiple drug-binding capacity of the AcrB multidrug efflux pump. Science 300:976-980.
237. Zgurskaya, H. I., and H. Nikaido. 2000. Multidrug resistance mechanisms: drug efflux across two membranes. Mol. Microbiol. 37:219-225.
238. Ziha-Zarifi, I., C. Llanes, T. Köhler, J.-C. Pechère, and P. Plésiat. 1999. In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM. Antimicrob. Agents Chemother. 43:287-291.
239. Zloh, M., G. W. Kaatz, and S. Gibbons. 2004. Inhibitors of multidrug resistance (MDR) have affinity for MDR substrates. Bioorg. Med. Chem. Lett. 14:881-885.